Kazazian Asset Management Has Raised Its Bristol Myers Squibb Co (BMY) Holding; Shorts at INTERCLOUD SYSTEMS (ICLD) Raised By 179.36%

January 18, 2018 - By Richard Conner

INTERCLOUD SYSTEMS INCORPORATED (OTCMKTS:ICLD) had an increase of 179.36% in short interest. ICLD’s SI was 377,700 shares in January as released by FINRA. Its up 179.36% from 135,200 shares previously. It closed at $0.003 lastly. It is down 0.00% since January 18, 2017 and is . It has underperformed by 16.70% the S&P500.

Kazazian Asset Management Llc increased Bristol Myers Squibb Co (BMY) stake by 46.93% reported in 2017Q3 SEC filing. Kazazian Asset Management Llc acquired 7,137 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Kazazian Asset Management Llc holds 22,344 shares with $1.42 million value, up from 15,207 last quarter. Bristol Myers Squibb Co now has $100.94 billion valuation. The stock decreased 0.29% or $0.18 during the last trading session, reaching $61.67. About 5.22M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 18, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

InterCloud Systems, Inc. provides networking orchestration and automation, for the Internet of things, software-defined networking , and network function virtualization (NFV) environments to telecommunications service well-known provider and corporate enterprise markets in the United States and internationally. The company has market cap of $1.77 million. It operates in three divisions: Applications and Infrastructure, Professional Services, and Managed Services. It currently has negative earnings. The firm offers integrated cloud managed solutions that allow organizations to migrate and integrate their applications into a public, private, or hybrid cloud environment; hardware solutions and applications, cloud managed solutions, and professional staffing services; and vendor-independent and multi-vendor virtual network function validation services.

Since September 6, 2017, it had 1 buying transaction, and 2 sales for $646,385 activity. Lynch Thomas J. Jr. sold $335,172 worth of stock or 5,300 shares. On Wednesday, September 6 Caldarella Joseph C sold $560,400 worth of Bristol-Myers Squibb Company (NYSE:BMY) or 9,340 shares. $249,187 worth of Bristol-Myers Squibb Company (NYSE:BMY) was bought by Samuels Theodore R. II.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: